|
Flagship Wet-Dry Vacuum Recognized for High-Temperature Steam Cleaning and Deep Hygienic Performance
HONG KONG, March 18, 2026 /PRNewswire/ -- Roborock today announced that its flagship wet-dry vacuum, the F25 Ultra, has been named a winner in the 2026 Clean House Awards by Better Homes & Gardens. Selected as one of just 50 standout products, the F25 Ultra rose to the top among nearly 200 products tested by editors and experts for its ability to deliver a deeper, more hygienic clean in modern homes.
Award-Winning Deep Cleaning Power for Spring Cleaning Season
As households prepare for spring cleaning season, the F25 Ultra stands out as a next-generation solution built for the realities of today's homes where pets, kids, high-traffic areas, and mixed flooring demand more than surface-level results. Designed to replace multiple cleaning tools with one streamlined system, the F25 Ultra delivers industry-first[1] dual high-temperature cleaning modes—steam and hot water—working together to break down stubborn messes at the source.
Powered by Roborock's VaporFlow™ and WaveFlow™ technologies, the system reaches up to 356°F steam[2] and 187°F hot water[3] to dissolve sticky residue, bacteria, and odors that traditional mopping can leave behind. This deep-penetrating clean is paired with 22,000 Pa of powerful suction[4] to lift embedded dirt, muddy paw prints, pet hair, liquid spills, and more in a single pass. Integrated blue light illumination helps reveal hidden dust and fine particles, especially along edges and in low-light areas, so nothing is missed.
Beyond raw cleaning power, the F25 Ultra is engineered for real-life usability. Its JawScrapers™ dual anti-tangle scraper roller helps deliver streak-free[5] floors while preventing hair wrap, supporting a smooth, low-maintenance experience. The DirTect™ Smart Sensor monitors dirt levels in real time, automatically adjusting cleaning intensity across different surfaces for optimal performance. AI-enhanced SlideTech 2.0 enables ultra-smooth maneuverability with responsive control, while FlatReach™ 2.0 allows the device to glide into tight spaces and maintain suction at 180°, even under beds and sofas.
Together, these technologies enable true one-pass wet and dry cleaning, the leaving floors visibly cleaner, sanitized, and ready for everyday living. For families tackling seasonal resets, pet messes, and daily buildup, the F25 Ultra delivers the deep hygienic performance modern homes demand year round.
Limited-Time Spring Cleaning Promotion
To celebrate the award recognition and the spring cleaning season, the Roborock F25 Ultra will be available at a special promotional price of $499.99 from March 25 - 31, allowing consumers to save $300 when purchasing through Amazon or Roborock's official website.
For more information about the Roborock F25 Ultra, please click here.
The 2026 Clean House Awards will be featured in the April 2026 issue of Better Homes & Gardens, which hits newsstands on March 20. The full list of winners can be found here.
About Roborock
Roborock is a leading smart cleaning brand renowned for its intelligent cleaning solutions. Having become the #1 best-selling robotic vacuum cleaner brand accounrd to IDC*, Roborock enriches lives with its innovative line of robotic, cordless, and wet-dry vacuum cleaners, robotic lawn mowers, and washer-dryers. Rooted in a user-centric approach, Roborock's R&D-driven solutions cater to diverse cleaning needs in millions of homes across more than 170 countries and regions. Headquartered in Beijing and with strategic subsidiaries in key markets, including the United States, Japan, the Netherlands, Poland, Germany, and South Korea, Roborock is dedicated to elevating its market presence worldwide. As of 2026, Roborock serves more than 22 million households. For more informaiton, visit https://global.roborock.com/.
*Sources:
Link : Global Home Cleaning Robot Market 2025: Chinese Brands Dominate as Lawn, Window, and Pool Robots Surge
IDC Worldwide Quarterly Smart Vacuum Robotics Tracker, 2025Q4
IDC Worldwide Quarterly Pool Cleaning Robotics Tracker, 2025Q4
IDC Worldwide Quarterly Lawn Mower Robotics Tracker, 2025Q4
IDC Worldwide Quarterly Smart Vacuum Robotics Tracker, 2025Q4
Footnotes
| [1] Based on Roborock's internal R&D records and available public information, Roborock was the first in the robot vacuum industry to mass-produce a wet & dry vacuum cleaner featuring both VaporFlow™ and WaveFlow™ - technologies enabling steam and hot water cleaning modes simultaneously, officially launched in Q3 2025. |
| [2] Based on internal testing by the manufacturer. The stated 356°F refers to the steam temperature measured at the internal heater output, not at the steam outlet. Actual performance may vary depending on environmental conditions. |
| [3] Based on internal testing by the manufacturer. The stated 187°F refers to the hot water temperature measured at the internal heater output, not at the water outlet. Actual performance may vary depending on environmental conditions. |
| [4] Based on internal testing by the manufacturer according to IEC 62885-2:2021/5.11 standards. Actual performance may vary depending on environmental conditions. |
| [5] Based on internal testing by the manufacturer. Actual performance may vary depending on environmental conditions. |
Flagship Wet-Dry Vacuum Recognized for High-Temperature Steam Cleaning and Deep Hygienic Performance
HONG KONG, March 18, 2026 /PRNewswire/ -- Roborock today announced that its flagship wet-dry vacuum, the F25 Ultra, has been named a winner in the 2026 Clean House Awards by Better Homes & Gardens. Selected as one of just 50 standout products, the F25 Ultra rose to the top among nearly 200 products tested by editors and experts for its ability to deliver a deeper, more hygienic clean in modern homes.
Award-Winning Deep Cleaning Power for Spring Cleaning Season
As households prepare for spring cleaning season, the F25 Ultra stands out as a next-generation solution built for the realities of today's homes where pets, kids, high-traffic areas, and mixed flooring demand more than surface-level results. Designed to replace multiple cleaning tools with one streamlined system, the F25 Ultra delivers industry-first[1] dual high-temperature cleaning modes—steam and hot water—working together to break down stubborn messes at the source.
Powered by Roborock's VaporFlow™ and WaveFlow™ technologies, the system reaches up to 356°F steam[2] and 187°F hot water[3] to dissolve sticky residue, bacteria, and odors that traditional mopping can leave behind. This deep-penetrating clean is paired with 22,000 Pa of powerful suction[4] to lift embedded dirt, muddy paw prints, pet hair, liquid spills, and more in a single pass. Integrated blue light illumination helps reveal hidden dust and fine particles, especially along edges and in low-light areas, so nothing is missed.
Beyond raw cleaning power, the F25 Ultra is engineered for real-life usability. Its JawScrapers™ dual anti-tangle scraper roller helps deliver streak-free[5] floors while preventing hair wrap, supporting a smooth, low-maintenance experience. The DirTect™ Smart Sensor monitors dirt levels in real time, automatically adjusting cleaning intensity across different surfaces for optimal performance. AI-enhanced SlideTech 2.0 enables ultra-smooth maneuverability with responsive control, while FlatReach™ 2.0 allows the device to glide into tight spaces and maintain suction at 180°, even under beds and sofas.
Together, these technologies enable true one-pass wet and dry cleaning, the leaving floors visibly cleaner, sanitized, and ready for everyday living. For families tackling seasonal resets, pet messes, and daily buildup, the F25 Ultra delivers the deep hygienic performance modern homes demand year round.
Limited-Time Spring Cleaning Promotion
To celebrate the award recognition and the spring cleaning season, the Roborock F25 Ultra will be available at a special promotional price of $499.99 from March 25 - 31, allowing consumers to save $300 when purchasing through Amazon or Roborock's official website.
For more information about the Roborock F25 Ultra, please click here.
The 2026 Clean House Awards will be featured in the April 2026 issue of Better Homes & Gardens, which hits newsstands on March 20. The full list of winners can be found here.
About Roborock
Roborock is a leading smart cleaning brand renowned for its intelligent cleaning solutions. Having become the #1 best-selling robotic vacuum cleaner brand accounrd to IDC*, Roborock enriches lives with its innovative line of robotic, cordless, and wet-dry vacuum cleaners, robotic lawn mowers, and washer-dryers. Rooted in a user-centric approach, Roborock's R&D-driven solutions cater to diverse cleaning needs in millions of homes across more than 170 countries and regions. Headquartered in Beijing and with strategic subsidiaries in key markets, including the United States, Japan, the Netherlands, Poland, Germany, and South Korea, Roborock is dedicated to elevating its market presence worldwide. As of 2026, Roborock serves more than 22 million households. For more informaiton, visit https://global.roborock.com/.
*Sources:
Link : Global Home Cleaning Robot Market 2025: Chinese Brands Dominate as Lawn, Window, and Pool Robots Surge
IDC Worldwide Quarterly Smart Vacuum Robotics Tracker, 2025Q4
IDC Worldwide Quarterly Pool Cleaning Robotics Tracker, 2025Q4
IDC Worldwide Quarterly Lawn Mower Robotics Tracker, 2025Q4
IDC Worldwide Quarterly Smart Vacuum Robotics Tracker, 2025Q4
Footnotes
[1] Based on Roborock's internal R&D records and available public information, Roborock was the first in the robot vacuum industry to mass-produce a wet & dry vacuum cleaner featuring both VaporFlow™ and WaveFlow™ - technologies enabling steam and hot water cleaning modes simultaneously, officially launched in Q3 2025.
[2] Based on internal testing by the manufacturer. The stated 356°F refers to the steam temperature measured at the internal heater output, not at the steam outlet. Actual performance may vary depending on environmental conditions.
[3] Based on internal testing by the manufacturer. The stated 187°F refers to the hot water temperature measured at the internal heater output, not at the water outlet. Actual performance may vary depending on environmental conditions.
[4] Based on internal testing by the manufacturer according to IEC 62885-2:2021/5.11 standards. Actual performance may vary depending on environmental conditions.
[5] Based on internal testing by the manufacturer. Actual performance may vary depending on environmental conditions.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Roborock F25 Ultra Named Winner in Better Homes & Gardens 2026 Clean House Awards
- Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody
- Technology licensed from Gates MRI; early studies confirm suppression of RSV infection
- Targeting global markets while addressing unmet needs in developing countries
INCHEON, South Korea, March 18, 2026 /PRNewswire/ -- SK bioscience announced on 18 that it has entered into a funding agreement with the Research Investment for Global Health Technology Foundation (RIGHT Foundation) to receive financial support for early clinical development of its RSV (respiratory syncytial virus) preventive monoclonal antibody candidate, RSM01.
The agreement was established following SK bioscience's selection as a recipient of the RIGHT Foundation's Product Development Award (PDA). Through this award, the company secured KRW 4 billion (approximately USD 3.0 million), the maximum funding available per project. Based on this support, SK bioscience plans to accelerate the Phase 1b clinical trial of RSM01 in infants.
RSM01 is a candidate RSV preventive therapeutic that SK bioscience licensed earlier this month from the Gates Medical Research Institute (Gates MRI), a nonprofit medical research organization. The candidate was designed by U.S. biotechnology company Adimab in collaboration with Gates MRI, which completed early research and a Phase 1a clinical trial. SK bioscience will oversee subsequent stages from the Phase 1b clinical trial through process development and commercialization.
RSM01 is designed to provide continuous protection throughout the RSV season with a single administration in newborns and infants. Non-clinical studies demonstrated effective suppression of RSV infection and replication, including activity against certain RSV strains with reduced responsiveness to existing preventive products.
Through the licensing agreement, SK bioscience obtained exclusive global supply rights, including high-income markets (non-exclusive in India and Gavi-eligible countries). Accordingly, the company plans a dual commercialization strategy: maximizing commercial value in advanced markets while supplying affordable doses through large-scale manufacturing to address unmet medical needs in lower-income countries.
RSV is a major respiratory virus causing severe lower respiratory tract infections in infants and young children worldwide, resulting in substantial hospitalizations and healthcare burden annually. According to global market research firm Evaluate Pharma, the global RSV preventive antibody market is projected to reach USD 4.5 billion (approximately KRW 6.6 trillion) by 2032. With limited currently available products and expanding immunization coverage in high-income countries, the market is expected to grow further.
Jinseon Park, COO of SK bioscience, said, "This funding agreement recognizes both the potential of the technology licensed from Gates MRI and our commitment to protecting global public health. By leveraging SK bioscience's world-class R&D and manufacturing capabilities, we will develop a globally competitive product."
In addition to the RSV preventive antibody, SK bioscience continues to strengthen its mid- to long-term growth foundation through a diversified infectious disease pipeline, including next-generation pneumococcal vaccines, universal coronavirus vaccines, avian influenza vaccines, and mRNA and next-generation vaccine platforms. The company aims to secure global competitiveness through an integrated development strategy connecting R&D, process development, manufacturing, and supply.
About SK bioscience
SK bioscience is an innovative vaccine and biotech company, committed to vaccine development and manufacturing to enable more equitable access to vaccines around the world. Leveraging strengths on cutting-edge technologies, SK bioscience has been dedicated to promoting human health from prevention to cure across the globe. With the cooperation of domestic and international governments, regulatory agencies, healthcare providers, doctors, and medical experts, all of the SK colleagues are passionately committed to providing high-quality vaccines to those who need them and better public healthcare solutions.
SK bioscience Communications Team
Changhyun Jin (jin99@sk.com)
Tae-Gyun Kim (taegyunkim@sk.com)
Moonchel Kim (mc_kim@sk.com)
INCHEON, South Korea, March 18, 2026 /PRNewswire/ -- SK bioscience announced on 18 that it has entered into a funding agreement with the Research Investment for Global Health Technology Foundation (RIGHT Foundation) to receive financial support for early clinical development of its RSV (respiratory syncytial virus) preventive monoclonal antibody candidate, RSM01.
The agreement was established following SK bioscience's selection as a recipient of the RIGHT Foundation's Product Development Award (PDA). Through this award, the company secured KRW 4 billion (approximately USD 3.0 million), the maximum funding available per project. Based on this support, SK bioscience plans to accelerate the Phase 1b clinical trial of RSM01 in infants.
RSM01 is a candidate RSV preventive therapeutic that SK bioscience licensed earlier this month from the Gates Medical Research Institute (Gates MRI), a nonprofit medical research organization. The candidate was designed by U.S. biotechnology company Adimab in collaboration with Gates MRI, which completed early research and a Phase 1a clinical trial. SK bioscience will oversee subsequent stages from the Phase 1b clinical trial through process development and commercialization.
RSM01 is designed to provide continuous protection throughout the RSV season with a single administration in newborns and infants. Non-clinical studies demonstrated effective suppression of RSV infection and replication, including activity against certain RSV strains with reduced responsiveness to existing preventive products.
Through the licensing agreement, SK bioscience obtained exclusive global supply rights, including high-income markets (non-exclusive in India and Gavi-eligible countries). Accordingly, the company plans a dual commercialization strategy: maximizing commercial value in advanced markets while supplying affordable doses through large-scale manufacturing to address unmet medical needs in lower-income countries.
RSV is a major respiratory virus causing severe lower respiratory tract infections in infants and young children worldwide, resulting in substantial hospitalizations and healthcare burden annually. According to global market research firm Evaluate Pharma, the global RSV preventive antibody market is projected to reach USD 4.5 billion (approximately KRW 6.6 trillion) by 2032. With limited currently available products and expanding immunization coverage in high-income countries, the market is expected to grow further.
Jinseon Park, COO of SK bioscience, said, "This funding agreement recognizes both the potential of the technology licensed from Gates MRI and our commitment to protecting global public health. By leveraging SK bioscience's world-class R&D and manufacturing capabilities, we will develop a globally competitive product."
In addition to the RSV preventive antibody, SK bioscience continues to strengthen its mid- to long-term growth foundation through a diversified infectious disease pipeline, including next-generation pneumococcal vaccines, universal coronavirus vaccines, avian influenza vaccines, and mRNA and next-generation vaccine platforms. The company aims to secure global competitiveness through an integrated development strategy connecting R&D, process development, manufacturing, and supply.
About SK bioscience
SK bioscience is an innovative vaccine and biotech company, committed to vaccine development and manufacturing to enable more equitable access to vaccines around the world. Leveraging strengths on cutting-edge technologies, SK bioscience has been dedicated to promoting human health from prevention to cure across the globe. With the cooperation of domestic and international governments, regulatory agencies, healthcare providers, doctors, and medical experts, all of the SK colleagues are passionately committed to providing high-quality vaccines to those who need them and better public healthcare solutions.
SK bioscience Communications Team
Changhyun Jin (jin99@sk.com)
Tae-Gyun Kim (taegyunkim@sk.com)
Moonchel Kim (mc_kim@sk.com)
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
